(Q37073662)

18 August 2017

1 reference

title

Co-factors in HIV neurobehavioural disturbances: substance abuse, hepatitis C and aging (English)

1 reference

18 August 2017

0 references

0 references

1 reference

1 reference

2

Mariana Cherner

1 reference

18 August 2017

Raul Gonzalez

1

1 reference

18 August 2017

publication date

1 February 2008

1 reference

International Review of Psychiatry

18 August 2017

published in

1 reference

18 August 2017

volume

20

1 reference

18 August 2017

issue

1

1 reference

18 August 2017

page(s)

49-60

1 reference

Short-term effects of cannabinoids in patients with HIV-1 infection: a randomized, placebo-controlled clinical trial

18 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Ethanol strongly potentiates apoptosis induced by HIV-1 proteins in primary human brain microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Cocaine-mediated enhancement of Tat toxicity in rat hippocampal cell cultures: the role of oxidative stress and D1 dopamine receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Physical activity, physical fitness, and risk of dying.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Accelerated Tau deposition in the brains of individuals infected with human immunodeficiency virus-1 before and after the advent of highly active anti-retroviral therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Neurobehavioural consequences of substance abuse and HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Influence of age at infection on human immunodeficiency virus disease progression to different clinical endpoints: the SEROCO cohort (1988-1994). The Seroco Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Drug and alcohol use and neuropsychological performance in asymptomatic HIV infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Short-term effects of cannabinoids on immune phenotype and function in HIV-1-infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Additive deleterious effects of methamphetamine dependence and immunosuppression on neuropsychological functioning in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Cognitive deficits and degeneration of interneurons in HIV+ methamphetamine users

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Additive effects of HIV and chronic methamphetamine use on brain metabolite abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

A multicenter in vivo proton-MRS study of HIV-associated dementia and its relationship to age.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Hepatitis C augments cognitive deficits associated with HIV infection and methamphetamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Neurologic consequences of hepatitis C and human immunodeficiency virus coinfection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Effect of chronic substance abuse on the neuropsychological performance of intravenous drug users with a high prevalence of HIV-1 seropositivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Comparison of neuropsychological performance between AIDS-free injecting drug users and homosexual men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Marijuana use and cognitive function in HIV-infected people

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

HIV-associated brain pathology in the United Kingdom: an epidemiological study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Microglial activation and its implications in the brain diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Is alcohol a cofactor of HIV and AIDS? Evidence from immunological and behavioral studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Opiates as potential cofactors in progression of HIV-1 infections to AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Relationship between alcohol use/abuse, HIV infection and neuropsychological performance in African American men

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Prevalence of Alzheimer plaques in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Interaction between HIV and intravenous heroin abuse?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Cocaine increases human immunodeficiency virus type 1 neuroinvasion through remodeling brain microvascular endothelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

A review of cognitive impairment and cerebral metabolite abnormalities in patients with hepatitis C infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Evidence for a cerebral effect of the hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Addictive drugs and their relationship with infectious diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Methamphetamine enhances cell-associated feline immunodeficiency virus replication in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Brain aging in acquired immunodeficiency syndrome: increased ubiquitin-protein conjugate is correlated with decreased synaptic protein but not amyloid plaque accumulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Accumulation of beta-amyloid precursor protein in HIV encephalitis: relationship with neuropsychological abnormalities.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Investigating neurocognitive features of hepatitis C virus infection in drug users: potential challenges and lessons learned from the HIV literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Cocaine abuse and HIV-1 infection: epidemiology and neuropathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

The effect of previous alcohol abuse on cognitive function in HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Neuropsychological aspects of coinfection with HIV and hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Methamphetamine administration produces immunomodulation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Epidemiology of Human Immunodeficiency Virus Infection and the Neurologic Complications of the Infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Effects of methamphetamine dependence and HIV infection on cerebral morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

The implications of the acquired immunodeficiency syndrome for gerontology research and geriatric medicine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Stroke associated with cocaine use.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Patterns of selective neuronal damage in methamphetamine-user AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

The role of mitochondrial alterations in the combined toxic effects of human immunodeficiency virus Tat protein and methamphetamine on calbindin positive-neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Negative-strand hepatitis C virus (HCV) RNA in peripheral blood mononuclear cells from anti-HCV-positive/HIV-infected women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Emerging evidence of hepatitis C virus neuroinvasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Cellular restoration in HIV infected persons treated with abacavir and a protease inhibitor: age inversely predicts naive CD4 cell count increase

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Pathogenesis of hepatitis C virus coinfection in the brains of patients infected with HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Methadone enhances human immunodeficiency virus infection of human immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Stroop performance in drug users classified by HIV and hepatitis C virus serostatus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Delayed nonmatch-to-sample performance in HIV-seropositive and HIV-seronegative polydrug abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Cannabinoids, immune system and cytokine network

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Effects of hepatic function and hepatitis C virus on the nervous system assessment of advanced-stage HIV-infected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Detection of hepatitis C virus genomic sequences in the cerebrospinal fluid of HIV-infected patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Neurotoxicity and dysfunction of dopaminergic systems associated with AIDS dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Tat and amyloid: multiple interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Beta amyloid precursor protein and patterns of HIV p24 immunohistochemistry in different brain areas of AIDS patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

In vivo effects of cocaine on immune cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Neuropsychological test performance in patients co-infected with hepatitis C virus and HIV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Endomorphin-1 potentiates HIV-1 expression in human brain cell cultures: implication of an atypical mu-opioid receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

The opioid-cytokine connection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Contribution of alcoholism to brain dysmorphology in HIV infection: effects on the ventricles and corpus callosum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Alcoholism and AIDS: magnetic resonance imaging approaches for detecting interactive neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Long-term methadone treatment: effect on CD4+ lymphocyte counts and HIV-1 plasma RNA level in patients with HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Search for hepatitis C virus negative-strand RNA sequences and analysis of viral sequences in the central nervous system: evidence of replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

HIV-1 Tat inhibits neprilysin and elevates amyloid beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Neuropsychological functioning in a cohort of HIV- and hepatitis C virus-infected women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Methamphetamine dependence increases risk of neuropsychological impairment in HIV infected persons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Tetrahydrocannabinol suppresses immune function and enhances HIV replication in the huPBL-SCID mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Heavy alcohol consumption in individuals with HIV infection: effects on neuropsychological performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Ischemic stroke associated with methamphetamine inhalation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Neuropsychiatric impact of hepatitis C on advanced HIV

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Low Education as a Possible Risk Factor for Cognitive Abnormalities in HIV-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Differential effect of HIV infection and alcoholism on conflict processing, attentional allocation, and perceptual load: evidence from a Stroop Match-to-Sample task

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Morphine stimulates HIV replication in primary cultures of human Kupffer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

What is cognitive reserve? Theory and research application of the reserve concept

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Neurobiology of cocaine-induced organic brain impairment: contributions from functional neuroimaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Mechanisms of the blood-brain barrier disruption in HIV-1 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Upregulation of microglia in drug users with and without pre-symptomatic HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Lewy bodies are not increased in progressive supranuclear palsy compared with normal controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Higher frequency of dementia in older HIV-1 individuals: the Hawaii Aging with HIV-1 Cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Opioid therapy and immunosuppression: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

The relationship between age and cognitive impairment in HIV-1 infection: findings from the Multicenter AIDS Cohort Study and a clinical cohort

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Clinical implications and methodological challenges in the study of the neuropsychological correlates of cannabis, stimulant, and opioid abuse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Psychomotor slowing in hepatitis C and HIV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Morphine inhibits CD8+ T cell-mediated, noncytolytic, anti-HIV activity in latently infected immune cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Is alcohol consumption a cofactor in the development of acquired immunodeficiency syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Chronic methamphetamine exposure alters immune function in normal and retrovirus-infected mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Cocaine opens the blood-brain barrier to HIV-1 invasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

Decreased recovery of CD4 lymphocytes in older HIV-infected patients beginning highly active antiretroviral therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09540260701872028

10.1080/09540260701872028

21 January 2018

Identifiers

DOI

1 reference

18 August 2017

1 reference